Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
An Pediatr (Barc) ; 60(6): 514-21, 2004 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-15207162

RESUMO

OBJECTIVES: To obtain a Spanish version of the Kindl semantically and culturally equivalent to the original German version and to test its psychometric properties. MATERIAL AND METHODS: The methodology used in the adaptation process was based on the forward-backward translation method. To assess the psychometric properties of the Spanish Kindl, the pilot test of the project "Screening for and promotion of HRQL in children and adolescents: a European Public Health perspective (Kidscreen)" it was include in. A classroom was selected for each educational level (8-16 years old) from three schools in Gerona and Barcelona. The Spanish Kindl was administered twice, one week apart. Internal consistency was assessed by computing Cronbach alpha and test-retest stability was assessed using intraclass correlation coefficients (ICC). Analysis of variance was performed according to age, sex, type of school, and self-perceived health status. RESULTS: Half of the items (12/24) required minor changes during the adaptation process. The response rate was 91 % (n = 447). Internal consistency was acceptable for most domains (alpha range = 0.40-0.88), as was test-retest stability (ICC range = 0.52-0.80). Girls and older teenagers scored worse in most domains (p < 0.01). No differences were found by type of school. CONCLUSIONS: The Spanish version of the Kindl showed adequate reliability and validity coefficients and represents a new HRQL instrument that can be applied in pediatric clinical practice and public health.


Assuntos
Indicadores Básicos de Saúde , Qualidade de Vida , Inquéritos e Questionários , Adolescente , Criança , Feminino , Alemanha , Humanos , Idioma , Masculino , Psicometria , Espanha
2.
Aliment Pharmacol Ther ; 14(12): 1631-8, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11121912

RESUMO

BACKGROUND: Empirical eradication therapy of H. pylori has been proposed as a therapeutic alternative for duodenal ulcer. AIM: To identify the cost-effectiveness of empirical eradication therapy vs. test-and-treatment for the management of patients already diagnosed with a duodenal ulcer. METHODS: A decision analysis was performed to compare the cost-effectiveness of empirical eradication therapy of H. pylori diagnosed duodenal ulcer vs. eradication therapy after confirmatory diagnosis of Helicobacter pylori infection by means of several diagnostic tests. RESULTS: The empirical eradication therapy of duodenal ulcer was found to be the most effective and cost-effective strategy of all the alternatives. Amongst the alternatives, which included the previous performance of confirmatory diagnostic tests, the best cost-effectiveness ratio used a serology test. The model was robust in the face of changes in the values of therapeutic effectiveness, sensitivity and specificity of the diagnostic tests, prevalence of H. pylori infection in duodenal ulcer, duration of the antisecretory therapy, and number of medical visits. CONCLUSIONS: Based on our cost-effectiveness analysis, a treat approach is more effective and cost-effective than a test-and-treat approach in the clinical management of already diagnosed duodenal ulcer.


Assuntos
Úlcera Duodenal/tratamento farmacológico , Custos de Cuidados de Saúde , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Análise Custo-Benefício , Técnicas de Apoio para a Decisão , Humanos
3.
Enferm Infecc Microbiol Clin ; 17 Suppl 2: 22-6, 1999.
Artigo em Espanhol | MEDLINE | ID: mdl-10605186

RESUMO

BACKGROUND: The advances of medicine over the last twenty years include the use of new tests and diagnostic methods in clinical practice. At the same time, we have witnessed the introduction of a strong movement, named Evidence Based Medicine, which basically includes a serious attempt for rationalizing the findings of more than 50 years of biomedical research, and to apply them properly to our patients as well as to the whole population. METHODS: Review of the published literature. All the recommendations are used in a practical example. RESULTS: Summary of the current existing recommendations for the assessment of a new diagnostic tool before its clinical application, and discussion of possible solutions for achieving a more efficient use of these tests. CONCLUSIONS: There are enough evidences for defining criteria for a uniform evaluation process of new diagnostic tests. The criteria could be useful for the clinical application of these tests.


Assuntos
Técnicas e Procedimentos Diagnósticos , Medicina Baseada em Evidências , Viés , Bibliometria , Controle de Custos , Análise Custo-Benefício , Técnicas e Procedimentos Diagnósticos/economia , Técnicas e Procedimentos Diagnósticos/normas , Técnicas e Procedimentos Diagnósticos/estatística & dados numéricos , Testes Diagnósticos de Rotina/economia , Testes Diagnósticos de Rotina/estatística & dados numéricos , Estudos de Avaliação como Assunto , Humanos , Padrões de Prática Médica , Valor Preditivo dos Testes
4.
Enferm Infecc Microbiol Clin ; 17 Suppl 2: 27-31, 1999.
Artigo em Espanhol | MEDLINE | ID: mdl-10605187

RESUMO

BACKGROUND: The re-emergence of bacterial diseases and their negative consequences in terms of health and economic cost, have made this issue an important public health problem. The objective of this work is to review the economic literature about antibiotic resistance, and to suggest possible solutions in our health care context aimed to reduce their negative impact. METHODS: We made a bibliographic search in the main biomedical databases. Economic assessment studies published in Spanish, English, French or Italian and related to the appearance of antibiotic resistance were selected. Their main methodological characteristics and results were analysed. RESULTS: Two studies analysing the economic impact of the appearance of antibiotic resistance were identified. A minimum hospital cost of 1300 million dollars (in 1992), and a social cost between 100 and 30,000 million dollars (in 1989) were estimated. CONCLUSIONS: Economic analysis allows to quantify and assess the impact of several management strategies in relation with antibiotic administration, in terms of health and costs, and to choose the most cost-effective strategies. The identification of inappropriate consumption of antibiotics as a cause of a negative externality upon the rest of the society is basic to make health care professionals and public opinion conscious about this problem, and to develop strategies to reduce its negative impact.


Assuntos
Antibacterianos/economia , Infecções Bacterianas/tratamento farmacológico , Resistência Microbiana a Medicamentos , Antibacterianos/uso terapêutico , Infecções Bacterianas/economia , Bibliometria , Administração de Caso/economia , Análise Custo-Benefício , Custos de Medicamentos , Europa (Continente) , Medicina Baseada em Evidências , Custos Hospitalares , Humanos , Fatores Socioeconômicos
5.
Am J Public Health ; 88(4): 551-7, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9550991

RESUMO

OBJECTIVES: This paper presents the results of different screening policies for prenatal detection of Down syndrome that would allow decision makers to make informed choices. METHODS: A decision analysis model was built to compare 8 screening policies with regard to a selected set of outcome measures. Probabilities used in the analysis were obtained from official administrative data reports in Spain and Catalonia and from data published in the medical literature. Sensitivity analyses were carried out to test the robustness of screening policies' results to changes in uptake rates, diagnostic accuracy, and resources consumed. RESULTS: Selected screening policies posed major trades-offs regarding detection rates, false-positive results, fetal loss, and costs of the programs. All outcome measures considered were found quite robust to changes in uptake rates. Sensitivity and specificity rates of screening tests were shown to be the most influential factors in the outcome measures considered. CONCLUSIONS: The disclosed trade-offs emphasize the need to comprehensively inform decision makers about both positive and negative consequences of adopting one screening policy or another.


Assuntos
Árvores de Decisões , Síndrome de Down/prevenção & controle , Programas de Rastreamento/métodos , Seleção de Pacientes , Gestantes , Diagnóstico Pré-Natal/métodos , Medição de Risco , Aborto Espontâneo/etiologia , Reações Falso-Positivas , Feminino , Política de Saúde , Humanos , Programas de Rastreamento/efeitos adversos , Programas de Rastreamento/economia , Avaliação de Resultados em Cuidados de Saúde , Gravidez , Diagnóstico Pré-Natal/efeitos adversos , Diagnóstico Pré-Natal/economia , Probabilidade , Fatores de Risco , Sensibilidade e Especificidade , Valores Sociais , Espanha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA